Text Size

Medical and Psychiatric Co-Morbidity Among Treatment Resistant Patients With Major Depression Disorder

This study has been completed.
Sponsor:
Information provided by:
Sheba Medical Center
ClinicalTrials.gov Identifier:
NCT00229398
First received: September 28, 2005
Last updated: January 28, 2008
Last verified: January 2008
History of Changes
  Purpose

Assessing psychiatric and physiological co-morbidity in TRD and non-TRD patients


Condition
Major Depressive Disorder

Study Type: Observational
Study Design: Time Perspective: Retrospective

Resource links provided by NLM:

MedlinePlus related topics: Depression
U.S. FDA Resources

Further study details as provided by Sheba Medical Center:

Study Start Date: November 1998
Study Completion Date: December 2004
Primary Completion Date: December 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Diagnosis of MDD
  • Received at least one adequate treatment

Exclusion Criteria:

-

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00229398

Sponsors and Collaborators
Sheba Medical Center
Investigators
Principal Investigator: Joseph Zohar, MD Tel Aviv University
  More Information

No publications provided

Responsible Party: Prof. Joseph Zohar, Chaim Sheba Medical Center
ClinicalTrials.gov Identifier: NCT00229398     History of Changes
Other Study ID Numbers: SHEBA-99-1744-JZ-CTIL
Study First Received: September 28, 2005
Last Updated: January 28, 2008
Health Authority: Israel: Israeli Health Ministry Pharmaceutical Administration

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
 Mood Disorders
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on June 18, 2013